直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Interferences

About

Interferences are still a viable proceeding for some patent applications
Although the first-to-file provision of the America Invents Act (AIA) effectively removed the option of an interference for most new patent applications, interferences remain viable for many U.S. patent applications containing claims entitled to earlier filing dates. Many rules of the Patent Trial and Appeal Board (PTAB) were built on prior interference practice, and several PTAB judges were on the predecessor Board of Patent Appeals and Interferences. For decades, Finnegan has counseled and represented clients in patent interferences, establishing one of the most highly regarded interference practices in the country. Our attorneys are adept at navigating through complicated priority fact patterns and the transitional AIA provisions to advise whether an interference is an appropriate tool. Known as priority contests to decide who was first to invent, interferences have also long provided an opportunity to contest patentability of a competitor’s claims under a lower standard of proof than is available in district court. Our extensive practice covers all technology disciplines and all degrees of complexity from simple, two-party interferences involving priority to more difficult cases involving multiple parties and multiple issues of priority and patentability.

Contacts

Michele C. Bosch
Partner
Washington, DC
+1 202 408 4193
Email
Timothy P. McAnulty
Partner
Washington, DC
+1 202 408 4348
Email
Mark D. Sweet
Partner
Washington, DC
+1 202 408 4162
Email
Michele C. Bosch
Partner
Washington, DC
+1 202 408 4193
Email
Timothy P. McAnulty
Partner
Washington, DC
+1 202 408 4348
Email
Mark D. Sweet
Partner
Washington, DC
+1 202 408 4162
Email

Everyone in this practice

Experience

Universal Electronics, Inc. v. Caavo Inc.
Represented patent owner Caavo as the junior party in two interferences related to audio-video switching devices. The PTAB granted judgment in favor of Caavo.

106,113; 106,114, PTAB, Judges Lane, Moore, Katz

Forward Pharma IP APS v. Biogen MA, Inc. 
Represented Biogen MA, Inc. in an interference proceeding before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) and obtained a favorable ruling for a patent covering Tecfidera®.

106,023, PTAB, Judges Gardner-Lane, Katz, Schafer

PQ Corp. v. Johnson Matthey PLC
Successfully represented PQ against Johnson Matthey in an interference related to chabazite type zeolites used for selective catalytic reduction of nitric oxides.

106,065, BPAI, Judges Schafer, Lane, Katz

Academisch Ziekenhuis Leiden v. University of Western Australia
Represented Sarepta and University of Western Australia in Federal Circuit appeals from interferences related to  Exondys 51® (eteplirsen) for Duchenne muscular dystrophy.

16-2262, 17-1078, Fed. Cir.

Academisch Ziekenhuis Leiden v. University of Western Australia
Member of team that represented Sarepta and University of Western Australia in Federal Circuit appeals from interferences related to  Exondys 51® (eteplirsen) for Duchenne muscular dystrophy.

16-1937, -2086, Fed. Cir.

Lo v. Quake
Represented Sequenom, Inc. et al in three interference cases before the PTAB and obtained favorable rulings relating to Dr. Dennis Lo’s inventions on noninvasive prenatal diagnostics.

105,920; 105,923; 105,924, PTAB, Judges Gardner-Lane, Katz, Moore

More

Insights

Federal Circuit IP Blog

Lack of Reasonable Expectation of Success Prohibits Finding of Interference-in-Fact

October 4, 2018

Seminar

Opposition and Appeal Procedures at the European Patent Office: What Every U.S. Practitioner Should Know

December 2, 2015

Menlo Park

Seminar

AIA Post-Grant Patent Practice

February 19-20, 2014

Arlington

News

Media Mention

Fed. Circ. Agrees Prenatal DNA Test Patent Doesn't Hold Up

July 10, 2019

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP